Compare TRAX & OCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TRAX | OCS |
|---|---|---|
| Founded | N/A | 2003 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 623.9M | 715.8M |
| IPO Year | 2026 | 2022 |
| Metric | TRAX | OCS |
|---|---|---|
| Price | $43.88 | $13.19 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $42.00 |
| AVG Volume (30 Days) | ★ 675.3K | 260.1K |
| Earning Date | N/A | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $466.06 |
| Revenue Next Year | N/A | $479.73 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $15.69 | $10.52 |
| 52 Week High | $49.91 | $34.48 |
| Indicator | TRAX | OCS |
|---|---|---|
| Relative Strength Index (RSI) | 63.47 | 58.08 |
| Support Level | $34.72 | $10.63 |
| Resistance Level | $49.75 | $13.28 |
| Average True Range (ATR) | 3.39 | 0.55 |
| MACD | -0.91 | 0.27 |
| Stochastic Oscillator | 44.65 | 93.49 |
Oculis Holding AG is a biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The Company has locations in five countries: Switzerland, Iceland, France, U.S. and Hong Kong.